Experience of transcather closure in patients with postinfarction ventricular septal defects.
- Author:
Yong SUN
1
;
Jie YUAN
;
Ruo-Xi ZHANG
;
Bo YU
Author Information
- Publication Type:Journal Article
- MeSH: Angioplasty, Balloon, Coronary; Cardiac Catheterization; adverse effects; Combined Modality Therapy; Heart Septal Defects, Ventricular; etiology; therapy; Humans; Myocardial Infarction; complications; drug therapy; Stents; Treatment Outcome
- From: Chinese Journal of Cardiology 2009;37(11):1002-1005
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo evaluate the therapeutic effect of transcather closure in patients with postinfarction ventricular septal defects (VSD).
METHODSTranscatheter VSD closure was performed in 12 patients with postinfarction VSD (10 muscular and 2 membranes defects) on top of standard pharmacotherapy and percutaneous transluminal coronary angioplasty (PTCA) as indicated.
RESULTS(1) Percutaneous interventional VSD closure was successful in 9 out 12 patients (75%) and these 9 patients survived post procedure. (2) The medial time between VSD occurrence and closure was (15.5 +/- 9.2) days. Procedure-related complications such as device embolization and malignant arrhythmia occurred in 3 patients (25%). The medial time between procedure and discharge from hospital was (11.3 +/- 5.2) days. (3) Coronary angiography was performed in 2 patients and 4 stents were implanted in diseased lesions.
CONCLUSIONTranscatheter closure could be successfully performed in selected patients with postinfarction VSD.